Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 1,408

Document Document Title
WO/2009/135449A1
The invention relates to novel ligands of the estrogen receptors α and β of general formula (II), which are useful as active substance of pharmaceuticals, for example pharmaceutical compositions useful for hormone replacement therapy, ...  
WO/2009/106360A2
The present invention relates to a method for purifying biodiesel, biodiesel precursors, or the mixtures thereof, which contain at least one glycoside, wherein biodiesel or a biodiesel precursor or a mixture thereof is incubated with at ...  
WO/2009/024103A3
The present invention relates to natural brassinosteroids of general formula (I), wherein R is CH2 or O-CH2 group, R2 is hydrogen or hydroxyl, R3 is hydroxyl, R24 is alkyl or alkenyl, which are selected from the group consisting of methy...  
WO/2009/023975A3
Provided is the novel sweetener and sweetness enhancer iso-mogroside V, compositions comprising the sweetener/sweetness enhancer for use in consumables (food products and products place in the oral cavity including mouth wash and other d...  
WO/2009/024103A2
The present invention relates to natural brassinosteroids of general formula (I), wherein R is CH2 or O-CH2 group, R2 is hydrogen or hydroxyl, R3 is hydroxyl, R24 is alkyl or alkenyl, which are selected from the group consisting of methy...  
WO/2009/023975A2
Provided is the novel sweetener and sweetness enhancer iso-mogroside V, compositions comprising the sweetener/sweetness enhancer for use in consumables (food products and products place in the oral cavity including mouth wash and other d...  
WO/2008/137599A3
Novel 2-alkoxyestradiol analogs, pharmaceutical compositions and methods of treatment of proliferative and angiogenesis associated conditions are disclosed.  
WO/2008/127381A3
This disclosure provides improved derivatives of artemisinin; pharamaceutical compositions containing these compounds; methods for preparing these compounds and compositions; methods of using these compounds and compositions for preventi...  
WO/2008/136199A1
A process for producing a compound represented by the following formula (2): (2) (wherein R1 means hydrogen, methyl, or CH2OH; R2 means hydrogen or methyl; R3 means hydrogen or hydroxy; R4 means hydrogen or hydroxy; and R5 means hydroxy,...  
WO/2008/127381A2
This disclosure provides improved derivatives of artemisinin; pharamaceutical compositions containing these compounds; methods for preparing these compounds and compositions; methods of using these compounds and compositions for preventi...  
WO/2008/109936A1
The present invention provides a compound of Formula I, pharmaceutical compositions and methods of use thereof.  
WO/2008/102716A1
Disclosed is an agent for treatment of ADHD-related diseases, which contains a compound represented by the formula (1) below or at least one pharmaceutically acceptable salt thereof as an active ingredient. (1) (In the formula, R1 and R2...  
WO/2008/078362A1
An antitumor agent containing at least one compound selected from the group consisting of nerigoside, oleandrigenin, sarmentoside, oleaside A, oleandrin, 8β-hydroxy odoroside A, narciclasine, trans-dihydronarciclasine and bisdeoxynarcic...  
WO/2007/039346A3
A photoresist composition including a polymer, a photoacid generator and a dissolution modification agent, a method of forming an image using the photoresist composition and the dissolution modification agent composition. The dissolution...  
WO/2008/047149A1
A stable aqueous pharmaceutical composition comprising anhydrous mometasone furoate and a pharmaceutically acceptable carrier.  
WO/2007/076163A3
The present disclosure concerns a process for removing steryl glycosides or monoacylglycerols from biodiesel by contact of the biodiesel with an absorbant, or filter aid. Treated biodiesel as well as steryl glycosides derived from biodie...  
WO/2008/028584A1
The invention relates to preparations for oral administration, containing (a) physiologically active fatty acids with 16 to 26 carbon atoms and 2 to 6 double bonds, the esters or glycerides thereof and (b) Hoodia extracts or the steroid ...  
WO/2008/026300A1
The object is to provide a novel therapeutic agent for malignant tumor. Disclosed is a therapeutic agent for malignant tumor or an apoptosis inducer which comprises a compound selected from epoxyazadiradione, gedunin, 17-epi-17-hydroxyaz...  
WO/2007/089688A3
This process relates to a pharmaceutical composition of an Na-K- ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition may be used to treat a skin disorder. ...  
WO/2008/022875A1
Process for preparing a composition comprising one or more steroidal glycosides, comprising the steps of: (a) harvesting Hoodia plants, (b) cutting up the harvested plants, (c) drying the cut plants, whereby exposure to UV light during t...  
WO/2007/070598A9
The present invention discloses compounds of formula (I): which exhibit antiviral properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in...  
WO/2007/112573A1
The present invention describes nitrate esters of sterols and stanols that bear an ascrobic acid moiety and a phosphate linking group, as well as pharmaceutically acceptable salts and stereoisomers thereof The invention also provides nov...  
WO/2007/115187A2
A platform service that is used by an application may be linked to an advertising service. A cost of using the platform service may be reduced based on the linking.  
WO/2007/060206A3
New crystalline forms of 17β-(3-Furyl)-5-βandrostane-3β,14β,17α-triol are described together with pharmaceutical composition containing the same and methods for their preparation. In particular new Forms B, C, D, E and H are here de...  
WO/2007/094166A1
A drug for recovery from a spinal cord injury, characterized by containing as an active ingredient a compound represented by the following structural formula (1) or a pharmaceutically acceptable salt thereof: Structural formula 1 (wherei...  
WO/2006/124012A3
The present invention provides compositions and methods for treating and preventing Alzheimer's disease by administering to a subject an effective amount of a dammarane or ginsenoside compound. The invention also provides compositions an...  
WO/2007/080951A1
The invention provides a novel process for the production of steroids, namely, a process for the production of 5β-3,7 -dioxocholanoic acid or ester derivatives thereof which comprises using as the raw material a sterol having double bon...  
WO2007016656A8
Methods for treatment of ocular disorders using steroids modulate the effects of local and systemic hypoxic events mediated by hypoxia inducible factor- 1 (HIF-1). Steroids that are useful as HIF-1 modulators include bufalin, digitoxigen...  
WO/2007/076163A2
The present disclosure concerns a process for removing steryl glycosides or monoacylglycerols from biodiesel by contact of the biodiesel with an absorbant, or filter aid. Treated biodiesel as well as steryl glycosides derived from biodie...  
WO/2007/070598A2
The present invention discloses compounds of formula (I): which exhibit antiviral properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in...  
WO/2006/113495A3
The present invention relates to a series of dicarboxylic acid ester derivatives of ginsenosides such as succinate and glutarate derivatives of 20-O-β-D- glucopyranosyl-protopanaxadiol (compound K, abbreviated as CK), preparation thereo...  
WO/2007/016656A3
Methods for treatment of ocular disorders using steroids modulate the effects of local and systemic hypoxic events mediated by hypoxia inducible factor- 1 (HIF-1). Steroids that are useful as HIF-1 modulators include bufalin, digitoxigen...  
WO/2007/060206A2
New crystalline forms of 17β-(3-Furyl)-5-βandrostane-3β,14β,17α-triol are described together with pharmaceutical composition containing the same and methods for their preparation. In particular new Forms B, C, D, E and H are here de...  
WO/2005/123959A3
High density multiplexing assays for proteins, nucleic acids, and other molecules are described based upon using mass spectrometry detection. A solid-state support assay format is utilized, whereby, the bead carries both a coding molecul...  
WO/2007/056326A2
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the Nav1.8 gene (Nav1.8 gene), comprising an antisense strand having a nucleotide sequence which is less that 25 nucleotides in length a...  
WO/2007/043302A1
Disclosed is a pharmaceutical or beverage/food which can inhibit the production of an adipocytokine, particularly an adipocytokine that can induce the resistance to insulin, to thereby prevent or ameliorate the occurrence of a morbid con...  
WO/2007/043305A1
Disclosed is a pharmaceutical or beverage/food which can inhibit the production of an adipocytokine, particularly an adipocytokine that can induce the resistance to insulin, to thereby prevent or ameliorate the occurrence of a morbid con...  
WO/2007/039346A2
A photoresist composition including a polymer, a photoacid generator and a dissolution modification agent, a method of forming an image using the photoresist composition and the dissolution modification agent composition. The dissolution...  
WO/2007/034851A1
Disclosed is a pharmaceutical or beverage/food which can reduce the fat accumulated in the abdominal cavity and can prevent or ameliorate visceral obesity which is believed to be the primary cause of metabolic syndrome. The pharmaceutica...  
WO/2007/006208A1
Medicinal composition containing ginseng secondary glycosides, its preparation method and application. The present composition contains mainly, as active ingredients, the ginsenoside with protopanoxadiol as aglucone (ginsenoside Rg3) and...  
WO/2006/124012A2
The present invention provides compositions and methods for treating and preventing Alzheimer's disease by administering to a subject an effective amount of a dammarane or ginsenoside compound. The invention also provides compositions an...  
WO/2006/123464A1
Use of 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol or compositions which consist of extracts of liliaceous plants or fractions thereof containing 3-O-β-D-glucopyranosyl-4-methyl- ergost-7-en-3-ol and contain the compound in amounts...  
WO/2006/113495A2
The present invention relates to a series of dicarboxylic acid ester derivatives of ginsenosides such as succinate and glutarate derivatives of 20-O-β-D- glucopyranosyl-protopanaxadiol (compound K, abbreviated as CK), preparation thereo...  
WO/2006/110810A2
The present invention relates to crystalline polymorphs of 3-O-(3',3'-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt ("DSB•2NMG)"), pharmaceutical compositions of the same and use of the same as an active pharmaceutical a...  
WO/2006/086377A2
The invention relates to a multiplex real-time RT-PCR assay with a heterologous internal control system (i.e., EGFP-RNA) for the simple and fast diagnosis of classical swine fever virus (CSFV). Primers and FAM-labeled TaqMan probes, spec...  
WO2006019685A3
The present invention provides novel ginsenoside compounds, compositions (e.g. pharmaceutical compositions) comprising the ginsenoside compounds, and methods for the synthesis of these ginsenoside compounds. Additionally, the present inv...  
WO/2006/052717A2
A glucuronide metabolite of tigecycline, and its corresponding epimer, have been identified in humans treated with tigecycline. Mass spectral data have been used to identify these structures.  
WO/2006/045171A2
The present invention refers to a process to obtain ergostane derivative dry steroids, such as physalins, including steps of: (a) grinding of dried parts of plant (s) from the Solanaceae species; (b) treatment of the said plant (s)' part...  
WO/2006/019685A2
The present invention provides novel ginsenoside compounds, compositions (e.g. pharmaceutical compositions) comprising the ginsenoside compounds, and methods for the synthesis of these ginsenoside compounds. Additionally, the present inv...  
WO2004028475A3
Glycosylceramide analogues are disclosed in which the ceramide moiety and optionally the carbohydrate moiety are modified or replaced. These analogues are useful as immunomodulators, antitumor agents, and as other pharmaceutical agents.  

Matches 101 - 150 out of 1,408